Angelalign Technology Inc
HKEX:6699
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CN |
|
Angelalign Technology Inc
HKEX:6699
|
12.5B HKD |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
201.9B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
178.4B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
148B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
125B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
113.6B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
47.8B EUR |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
52.6B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
50.3B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
50.3B USD |
Loading...
|
|
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
38.3B USD |
Loading...
|
Market Distribution
| Min | -416 945.9% |
| 30th Percentile | -1.5% |
| Median | 3.5% |
| 70th Percentile | 8.9% |
| Max | 17 382.1% |
Other Profitability Ratios
Angelalign Technology Inc
Glance View
Angelalign Technology Inc., nestled in the ever-evolving healthcare landscape, has carved out its niche as a pivotal player in the orthodontics market, specifically through the design and production of clear aligners. Founded in 2003, this company has capitalized on growing aesthetic consciousness and technological advancements that converge in the orthodontic marketplace. Its core business thrives on innovation, leveraging digital orthodontic treatment solutions that streamline the traditionally cumbersome process of teeth alignment. By utilizing proprietary 3D printing and advanced imaging technology, Angelalign crafts personalized aligners that cater to the unique dental structure of each patient, enhancing comfort and effectiveness. These solutions are marketed to orthodontists and dental professionals, who then offer them to patients seeking alternatives to conventional braces, thus tapping into the escalating demand for oral health solutions that marry efficacy with cosmetic appeal. Angelalign's revenue stream primarily flows from the sales of its clear aligners, but the path to profitability goes beyond just product sales. The company has adeptly built an ecosystem around its core offerings, supplementing aligner sales with comprehensive support services to orthodontic practices. This includes digital platforms for patient management and treatment planning, ensuring a seamless integration with the routine operations of dental clinics. Furthermore, Angelalign invests meticulously in its R&D, continuously refining its technology and expanding its treatment capabilities, which fuels repeat business and consolidates its brand reputation. By embedding itself as a partner to dental professionals and focusing on delivering superior patient outcomes, Angelalign Technology Inc. not only seizes a significant market share but also positions itself as a beacon of orthodontic innovation within the broader healthcare technology sector.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Angelalign Technology Inc is 7.6%, which is above its 3-year median of 6.3%.
Over the last 3 years, Angelalign Technology Inc’s Net Margin has decreased from 20.8% to 7.6%. During this period, it reached a low of 2.5% on Jun 30, 2024 and a high of 20.8% on Jun 30, 2022.